https://www.selleckchem.com/products/gw9662.html
fusion period and along with the proportional development of renal dysfunctions. Recent literature has separately identified multiple determinants of the use of neoadjuvant chemotherapy (NAC) and adherence to pelvic lymphnode dissection (PLND) guidelines in the management of non-metastatic bladder cancer. However, such NAC/PLND analyses tend not to account for the other modality, despite the fact that NAC may impact the extent of dissectible lymph nodes. We aimed to determine the predictors of adequate PLND in patients with non-metastati
Beğen
Yorum Yap
Paylaş
